Stability study of an aqueous formulation of captopril at 1 mg/ml;Estudio de estabilidad de soluciones acuosas de captopril en concentración de 1 mg/ml

Farmacia Hospitalaria

Volumn 29, Issue 1, 2005, Pages 30-36

  Escribano Garcia M J ^a   Torrado Durán, Santiago ^b   Torrado Duran J J ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antioxidants agents; Captopril; Captopril disulfide; Chelating agents; Stability

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CAPTOPRIL; CAPTOPRIL DISULFIDE; CHELATING AGENT; DRUG VEHICLE; EDETIC ACID; MINERAL WATER; SODIUM METABISULFITE; TAP WATER; UNCLASSIFIED DRUG;

ARTICLE; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID; PH; POWDER;

EID: 16444372763     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1130-6343(05)73633-3     Document Type: Article

References (17)

1. Parfitt K. The Complete Drug Reference. 32 ed. London: Pharmaceutical Press, 1999. p. 836-7.
2. Catálogo de Especialidades Farmacéuticas 2003. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos, 2003. p. 824-6.
3. a en español), Madrid: Ministerio de Sanidad y Consumo, 1995.
4. USP 26, N.F. 21. United States Pharmacopeial convention. Inc, Rockville MD, 2003. p. 319-21.
5. Takemoto CK, Chu SA, Cheng MH, Corpuz RP. Stability of captopril in powder papers under three storage conditions. Am J Hosp Pharm 1990; 47: 1799-801.
6. Chan D Sch, Sato AK, Claybaugh JR. Degradation of captopril in solutions compounded from tablets and standard powder. Am J Hosp Pharm 1994; 51: 1205-7.
7. Pramar Y, Das Gupta V, Bethea C. Stability of captopril in some aqueous systems. J Clin Pharm Ther 1992; 17: 185-9.
8. Formulations. Captopril 0,75 mg/ml Oral Liquid. International Journal of Pharmaceutical Compounding 1997; 1: 322.
9. Anaizi NH, Swenson C. Instability of aqueous captopril solutions. Am J Hosp Pharm 1993; 50: 486-8.
10. Pereira CM, Tam YK. Stability of captopril in tap water. Am J Hosp Pharm 1992; 49: 612-5.
11. Lye MYF, Yow KL, Lim LY, Chan SY, Chan E, Ho PC. Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids. Am J Health-Syst Pharm 1997; 54: 2483-7.
12. Nahata MC, Morosco RS, Hippie TF. Stability of captopril in liquid containing ascorbic acid or sodium ascorbate. Am J Hosp Pharm 1994; 51: 1707-8.
13. Nahata MC, Morosco RS, Hipple TF. Stability of captopril in three liquid dosage forms. Am J Hosp Pharm 1994; 51: 95-6.
14. Bpharm WJ, Ho PC. Stability of captopril in invert sugar solution. J Clin Pharm Ther 1998; 23: 451-6.
15. rd. Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids. Am J Health Syst Pharm 1996; 53: 2179-84.
16. Formulario Nacional. Primera Edición. Madrid: Ministerio de Sanidad y Consumo, 2003.
17. a Ed. Alicante: Colegio Oficial de Farmacéuticos de la Provincia de Alicante. 1988. p. 214-5.